CHANDAN SAMRA: Open Payments
NPI 1114422326 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$700 in 6 payments from 5 companies in 2025. Trend: 2023 $738 · 2024 $546 · 2025 $700
Food & beverage: $700
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $248 |
| Alkermes, Inc. | 1 | $124 |
| Otsuka America Pharmaceutical, Inc. | 1 | $110 |
| Axsome Therapeutics, Inc. | 1 | $109 |
| Teva Pharmaceuticals USA, Inc. | 1 | $108 |
Products named: CAPLYTA, LYBALVI, ABILIFY ASIMTUFII, Auvelity, UZEDY.
Industry payments across CA — which companies pay providers there.
